MedTrace Logo

Molecular Assessment of Artemisinin Resistance Markers in Eastern and Western Border Areas of Myanmar

NCT02198573 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2014-07-23

No results posted yet for this study

Summary

* Artemisinin resistance have been documented in Myanmar and Myanmar artemisinin resistance containment measures have been launched since 2009-2010.
* It is important to monitor the spread and magnitude of artemisinin resistant malaria in Myanmar.
* So, day-3 surveillance study have been conducted.
* Recently artemisinin resistant molecular marker, K13 have been identified and it was used as a tool in this study.

Conditions

  • Day-3 Positive of Parasitaemia
  • Prevalence of Drug Resistance Gene Mutation

Sponsors & Collaborators

  • Kangwon National University

    collaborator OTHER

  • Myat Htut Nyunt

    lead OTHER

Principal Investigators

  • Myat P Kyaw, PhD · Department of Medical Research, Lower Myanmar

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-12-31
Completion
2014-06-30

Countries

  • Burma

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02198573 on ClinicalTrials.gov